麻醉疼痛指南

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛指南

2022 ESAIC/ESRA 联合指南：抗血栓药物患者的区域麻醉

2022-02-01 欧洲麻醉和重症监护学会 Eur J Anaesthesiol

抗血栓药物患者的区域麻醉

出血是椎管内和周围神经阻滞后的潜在并发症。服用抗血小板和抗凝药物的患者风险增加。这份来自欧洲麻醉与重症监护学会和欧洲区域麻醉学会的联合指南旨在就如何降低与区域麻醉实践相关的抗血栓药物引起的血肿形成风险

中文标题：

2022 ESAIC/ESRA 联合指南：抗血栓药物患者的区域麻醉

发布机构：

欧洲麻醉和重症监护学会

发布日期：

2022-02-01

简要介绍：

出血是椎管内和周围神经阻滞后的潜在并发症。服用抗血小板和抗凝药物的患者风险增加。这份来自欧洲麻醉与重症监护学会和欧洲区域麻醉学会的联合指南旨在就如何降低与区域麻醉实践相关的抗血栓药物引起的血肿形成风险提供一套基于证据的建议和建议。麻醉和镇痛。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 ESAIC_ESRA 联合指南：抗血栓药物患者的区域麻醉.pdf)] GetToolGuiderByIdResponse(projectId=1, id=86c1d1c002369e1e, title=2022 ESAIC/ESRA 联合指南：抗血栓药物患者的区域麻醉, enTitle=, guiderFrom=Eur J Anaesthesiol , authorId=0, author=, summary=出血是椎管内和周围神经阻滞后的潜在并发症。服用抗血小板和抗凝药物的患者风险增加。这份来自欧洲麻醉与重症监护学会和欧洲区域麻醉学会的联合指南旨在就如何降低与区域麻醉实践相关的抗血栓药物引起的血肿形成风险, cover=https://img.medsci.cn/2022227/1645972187181_1608702.png, journalId=0, articlesId=null, associationId=2271, associationName=欧洲麻醉和重症监护学会, associationIntro=欧洲麻醉和重症监护学会(ESAIC,European Society of Anaesthesiology and Intensive Care), copyright=0, guiderPublishedTime=Tue Feb 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #212121;">出血是椎管内和周围神经阻滞后的潜在并发症。</span><span style="color: #212121;">服用抗血小板和抗凝药物的患者风险增加。</span><span style="color: #212121;">这份来自欧洲麻醉与重症监护学会和欧洲区域麻醉学会的联合指南旨在就如何降低与区域麻醉实践相关的抗血栓药物引起的血肿形成风险提供一套基于证据的建议和建议。麻醉和镇痛。</span></p>, tagList=[TagDto(tagId=123687, tagName=抗血栓药物患者的区域麻醉)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6855, appHits=137, showAppHits=0, pcHits=376, showPcHits=6718, likes=0, shares=22, comments=2, approvalStatus=1, publishedTime=Mon Feb 28 15:27:00 CST 2022, publishedTimeString=2022-02-01, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Sun Feb 27 22:30:00 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 21:11:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ESAIC_ESRA 联合指南：抗血栓药物患者的区域麻醉.pdf)])
2022 ESAIC_ESRA 联合指南：抗血栓药物患者的区域麻醉.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1205101, encodeId=2e1e120510142, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Wed Mar 23 06:03:56 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199995, encodeId=62d4119999578, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sun Mar 06 19:51:06 CST 2022, time=2022-03-06, status=1, ipAttribution=)]
    2022-03-23 12347d7bm83(暂无昵称)

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1205101, encodeId=2e1e120510142, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Wed Mar 23 06:03:56 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199995, encodeId=62d4119999578, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sun Mar 06 19:51:06 CST 2022, time=2022-03-06, status=1, ipAttribution=)]
    2022-03-06 130a765fm69暂无昵称

    #学习#

    0